News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,896 Results
Type
Article (10127)
Company Profile (8)
Press Release (57761)
Section
Business (13721)
Career Advice (277)
Deals (2134)
Drug Delivery (5)
Drug Development (12778)
Employer Resources (10)
FDA (2039)
Job Trends (1226)
News (29782)
Policy (2523)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Beach Digital (1)
Academia (703)
Accelerated approval (2)
Adcomms (6)
Allergies (3)
Alliances (4287)
ALS (42)
Alzheimer's disease (1071)
Antibody-drug conjugate (ADC) (8)
Approvals (2020)
Artificial intelligence (28)
Autoimmune disease (1)
Automation (1)
Bankruptcy (20)
Best Places to Work (1161)
Biosimilars (5)
Biotechnology (9)
Bladder cancer (2)
Brain cancer (31)
Breast cancer (29)
Cancer (256)
Cardiovascular disease (14)
Career advice (244)
Career pathing (6)
CAR-T (9)
Cell therapy (40)
Cervical cancer (2)
Clinical research (9803)
Collaboration (109)
Compensation (22)
Complete response letters (8)
COVID-19 (238)
CRISPR (4)
C-suite (32)
Cystic fibrosis (2)
Data (359)
Depression (24)
Diabetes (25)
Diagnostics (506)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (23)
Drug pricing (3)
Duchenne muscular dystrophy (5)
Earnings (4478)
Editorial (8)
Employer resources (13)
Events (8644)
Executive appointments (62)
FDA (2233)
Featured Employer (1)
Frontotemporal dementia (3)
Funding (118)
Gene editing (8)
Generative AI (1)
Gene therapy (69)
GLP-1 (90)
Government (380)
Guidances (2)
Healthcare (2210)
Huntington's disease (16)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (4)
Infectious disease (246)
Inflammatory bowel disease (4)
Influenza (4)
Intellectual property (9)
Interviews (48)
IPO (992)
IRA (3)
Job creations (131)
Job search strategy (201)
Layoffs (31)
Leadership (8)
Legal (309)
Liver cancer (2)
Lung cancer (64)
Lymphoma (17)
Management (9)
Manufacturing (13)
MASH (5)
Medical device (1351)
Medtech (1352)
Mergers & acquisitions (1189)
Metabolic disorders (70)
Multiple sclerosis (39)
NASH (2)
Neurodegenerative disease (56)
Neuropsychiatric disorders (6)
Neuroscience (1355)
NextGen: Class of 2025 (706)
Non-profit (784)
Northern California (299)
Obesity (41)
Opinion (43)
Pain (20)
Pancreatic cancer (5)
Parkinson's disease (95)
Partnered (1)
Patents (31)
Patient recruitment (21)
Peanut (2)
People (4087)
Phase I (3065)
Phase II (4572)
Phase III (3172)
Pipeline (150)
Policy (8)
Postmarket research (367)
Preclinical (1496)
Prostate cancer (5)
Psychedelics (8)
Radiopharmaceuticals (35)
Rare diseases (69)
Real estate (285)
Recruiting (2)
Regulatory (2117)
Reports (3)
Research institute (655)
Resumes & cover letters (25)
Rett syndrome (1)
RNA editing (1)
RSV (2)
Schizophrenia (25)
Series A (20)
Series B (14)
Sickle cell disease (6)
Southern California (231)
Special edition (3)
Spinal muscular atrophy (34)
Sponsored (5)
Startups (372)
Stomach cancer (1)
Supply chain (2)
Tariffs (2)
The Weekly (1)
United States (2573)
Vaccines (62)
Venture capitalists (3)
Weight loss (17)
Women's health (1)
Worklife (5)
Date
Today (13)
Last 7 days (71)
Last 30 days (278)
Last 365 days (4076)
2025 (1214)
2024 (4321)
2023 (4756)
2022 (5779)
2021 (5885)
2020 (5047)
2019 (4916)
2018 (3546)
2017 (3490)
2016 (3560)
2015 (4094)
2014 (3030)
2013 (2680)
2012 (2607)
2011 (2263)
2010 (1951)
Location
Africa (81)
Alabama (1)
Arizona (12)
Arkansas (2)
Asia (4014)
Australia (1072)
California (585)
Canada (325)
China (38)
Colorado (19)
Connecticut (32)
Delaware (4)
Europe (10180)
Florida (115)
Georgia (24)
Idaho (9)
Illinois (57)
India (1)
Indiana (34)
Japan (27)
Kansas (27)
Kentucky (8)
Maine (2)
Maryland (77)
Massachusetts (562)
Michigan (6)
Minnesota (34)
Missouri (8)
Montana (1)
Nebraska (2)
Nevada (8)
New Jersey (153)
New Mexico (6)
New York (282)
North Carolina (80)
North Dakota (1)
Northern California (299)
Ohio (21)
Oklahoma (1)
Oregon (5)
Pennsylvania (150)
Rhode Island (7)
South America (110)
Southern California (231)
Tennessee (29)
Texas (176)
Utah (16)
Virginia (23)
Washington D.C. (1)
Washington State (70)
Wisconsin (4)
67,896 Results for "emotional brain bv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVersys Announces Important BV100 Patent Granted by Chinese Patent Office
March 31, 2025
·
5 min read
Press Releases
BioVersys to Present BV100 Phase 2 Data at 35th ESCMID Global 2025
April 8, 2025
·
10 min read
Press Releases
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
April 28, 2025
·
4 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Brain cancer
Biopharma Takes on Deadly Brain Cancer After Decades of Failure
Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal brain tumor.
December 2, 2024
·
7 min read
·
Kate Goodwin
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
January 7, 2025
·
3 min read
Biotech Bay
Phenomix Sciences Launches Three-in-One Obesity Phenotyping Test, Adding Emotional Hunger and Personalized Lifestyle Guidance
Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces the launch of a new MyPhenomeTM test that now allows patients to test for all three identified phenotypes - Emotional Hunger, Hungry Gut and Hungry Brain - in one simple test.
April 4, 2024
·
3 min read
1 of 6,790
Next
